Entrada Therapeutics CFO Wentworth Kory James forfeited 1,733 shares at $7.14 per share, leaving him with 117,277 shares after the transaction. The remaining ownership figure gives investors a precise view of his disclosed stake following the share forfeiture, without indicating any broader change to Entrada Therapeutics.

Key Highlights

  • Wentworth Kory James held 117,277 Entrada Therapeutics shares after the transaction.
  • The forfeiture occurred on Sep. 2, 2026.
  • James is Entrada Therapeutics’ chief financial officer.

Entrada Therapeutics, Inc. (NASDAQ: TRDA) saw Chief Financial Officer Wentworth Kory James forfeit 1,733 shares at $7.14 per share. The transaction left James with 117,277 shares.

James Retains 117,277 Shares

The share forfeiture took place on Sep. 2, 2026. The disclosed price was $7.14 for each forfeited share. His ownership following the transaction was 117,277 shares.